Biblio Discovery — Demo Discovery Service

9 results for "John Post"

Showing 1–9 · 1.63 seconds · RSS

  1. Journal Article

    Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus

    Penny Clohessy; Juan Merif; Jeffrey John Post

    International Journal of Infectious Diseases, Vol. 29 No. C · 2014 · English · DOAJ Scopus

    Background: Clostridium difficile infection (CDI) is increasingly being found in populations without traditional risk factors. We compared the relative frequency, risk factors, severity, and outcomes of community-onset CDI with hospital-acquired infection. Methods: This was a retrospective…

  2. Journal Article

    Preserving Mobile Home Communities through Shared-Equity Ownership Mechanisms: A Case Study of the Burnsville Land Community (BLC)

    Terence M Milstead; John Post; Rosie Tighe

    Journal of Rural and Community Development, Vol. 8 No. 1 · 2013 · French · DOAJ

    As sprawl and an increase of new residents in many rural areas in Western North Carolina (WNC) lead to increased land values, the owners of many mobile home communities (MHCs) are selling the land for development, resulting in the displacement of tenants. In some areas of the U.S. residents of MHCs…

  3. Journal Article Full text

    Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study.

    Melissa Louise Kelly; Stephen M Riordan; Rohan Bopage et al.

    PLoS ONE, Vol. 13 No. 2 · 2018 · English · DOAJ Scopus

    IntroductionAchievement of the 2030 World Health Organisation (WHO) global hepatitis C virus (HCV) elimination targets will be underpinned by scale-up of testing and use of direct-acting antiviral treatments. In Australia, despite publically-funded testing and treatment, less than 15% of patients…

    Also available at: PLOS

  4. Journal Article

    Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening

    De Lin; Lesley-Anne Pearson; Shamshad Ahmad et al.

    SLAS Discovery, Vol. 35 · 2025 · English · DOAJ Scopus

    False-positives plague high-throughput screening in general and are costly as they consume resource and time to resolve. Methods that can rapidly identify such compounds at the initial screen are therefore of great value. Advances in mass spectrometry have led to the ability to screen inhibitors in…

  5. Journal Article Full text

    Identification of Leishmania major UDP-Sugar Pyrophosphorylase Inhibitors Using Biosensor-Based Small Molecule Fragment Library Screening

    Ohm Prakash; Jana Führing; John Post et al.

    Molecules, Vol. 24 No. 5 · 2019 · English · DOAJ Scopus

    Leishmaniasis is a neglected disease that is caused by different species of the protozoan parasite Leishmania, and it currently affects 12 million people worldwide. The antileishmanial therapeutic arsenal remains very limited in number and efficacy, and there is no vaccine for this parasitic…

  6. Journal Article

    Mechanistic insights into dual-active liver and blood-stage antiplasmodials

    Mukul Rawat; Nonlawat Boonyalai; Cindy Smidt et al.

    mBio, Vol. 17 No. 1 · 2025 · English · DOAJ Scopus

    ABSTRACT The identification of novel antimalarials with activity against both the liver and blood stages of the parasite lifecycle would have the dual benefit of prophylactic and curative potential. However, one challenge of leveraging chemical hits from phenotypic screens is subsequent target…

  7. Journal Article

    Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site

    Vitor Mendes; Simon R. Green; Joanna C. Evans et al.

    Nature Communications, Vol. 12 No. 1 · 2021 · English · DOAJ Scopus

    The bifunctional enzyme CoaBC catalyses the second and third step in the Coenzyme A (CoA) biosynthesis pathway and is of interest as a M. tuberculosis drug target. Here, the authors present the full-length crystal structure of Mycobacterium smegmatis CoaBC, which is regulated by CoA and CoA…

  8. Journal Article

    Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs

    Simon R. Green; Susan H. Davis; Sebastian Damerow et al.

    Nature Communications, Vol. 13 No. 1 · 2022 · English · DOAJ Scopus

    Tuberculosis is a major cause of mortality, and the rise of drug-resistant strains of Mycobacterium tuberculosis requires the urgent development of safe and effective treatments. In this work, the authors develop a compound against lysyl-tRNA synthetase, demonstrating on-target mechanism of action…